These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 15180832)

  • 1. The promise and challenges of personalized medicine for eye diseases.
    McCarty CA
    Clin Exp Ophthalmol; 2004 Jun; 32(3):236-7. PubMed ID: 15180832
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacogenomics: the promise of personalized medicine.
    Hood E
    Environ Health Perspect; 2003 Aug; 111(11):A581-9. PubMed ID: 12928155
    [No Abstract]   [Full Text] [Related]  

  • 3. Getting to personalized cancer medicine: taking out the garbage.
    Compton C
    Cancer; 2007 Oct; 110(8):1641-3. PubMed ID: 17763370
    [No Abstract]   [Full Text] [Related]  

  • 4. Genomic promise: personalized medicine for ophthalmology.
    Wiggs JL
    Arch Ophthalmol; 2008 Mar; 126(3):422-3. PubMed ID: 18332327
    [No Abstract]   [Full Text] [Related]  

  • 5. Personalized medicine prompts push to redesign clinical trials.
    Singer E
    Nat Med; 2005 May; 11(5):462. PubMed ID: 15875041
    [No Abstract]   [Full Text] [Related]  

  • 6. Personalized medicine.
    Jain KK
    Curr Opin Mol Ther; 2002 Dec; 4(6):548-58. PubMed ID: 12596356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personalized medicine: the translation of genetic knowledge to eye care.
    MacDonald IM
    Can J Ophthalmol; 2008 Feb; 43(1):15-7. PubMed ID: 18204502
    [No Abstract]   [Full Text] [Related]  

  • 8. The disruptive nature of personalized medicine technologies: implications for the health care system.
    Carlson RJ
    Public Health Genomics; 2009; 12(3):180-4. PubMed ID: 19204421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The conundrum of personalized cancer management, drug development, and economics.
    DeNardo GL
    Cancer Biother Radiopharm; 2007 Dec; 22(6):719-21. PubMed ID: 18158762
    [No Abstract]   [Full Text] [Related]  

  • 10. From pharmacogenetics to personalized medicine: a vital need for educating health professionals and the community.
    Frueh FW; Gurwitz D
    Pharmacogenomics; 2004 Jul; 5(5):571-9. PubMed ID: 15212593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing patient readiness for the clinical adoption of personalized medicine.
    Issa AM; Tufail W; Hutchinson J; Tenorio J; Baliga MP
    Public Health Genomics; 2009; 12(3):163-9. PubMed ID: 19204419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The microeconomics of personalized medicine: today's challenge and tomorrow's promise.
    Davis JC; Furstenthal L; Desai AA; Norris T; Sutaria S; Fleming E; Ma P
    Nat Rev Drug Discov; 2009 Apr; 8(4):279-86. PubMed ID: 19300459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming the FDA in the age of personalized medicine-interview with Ray Woosley.
    Musgrave E
    Clin Transl Sci; 2008 May; 1(1):5. PubMed ID: 20443811
    [No Abstract]   [Full Text] [Related]  

  • 14. -Omics dreams of personalized healthcare.
    Nicholson JK
    J Proteome Res; 2006 Sep; 5(9):2067, 2069. PubMed ID: 16969945
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacogenomics in pediatrics: personalized medicine showing eminent promise.
    Mele C; Goldschmidt K
    J Pediatr Nurs; 2014; 29(4):378-82. PubMed ID: 24880100
    [No Abstract]   [Full Text] [Related]  

  • 16. Improving the power of diagnostics in the era of targeted therapy and personalized healthcare.
    Walk EE
    Curr Opin Drug Discov Devel; 2010 Mar; 13(2):226-34. PubMed ID: 20205056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenetics of pharmacoecology: which route to personalized medicine?
    Robertson GR; Grant DM; Piquette-Miller M
    Clin Pharmacol Ther; 2009 Apr; 85(4):343-8. PubMed ID: 19295529
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacogenomics and personalized medicine: mapping of future value creation.
    Hu SX; Foster T; Kieffaber A
    Biotechniques; 2005 Oct; 39(10 Suppl):S1-6. PubMed ID: 18957035
    [No Abstract]   [Full Text] [Related]  

  • 19. Commentary: where and how could biomarkers be used in 2016?
    Finley Austin MJ; Babiss L
    AAPS J; 2006; 8(1):E185-9. PubMed ID: 16596744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The current status and future potential of personalized diagnostics: Streamlining a customized process.
    Richmond TD
    Biotechnol Annu Rev; 2008; 14():411-22. PubMed ID: 18606372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.